Navigation Links
BioPlus Specialty Pharmacy Releases Updated Version of ‘HCV Treatment Path’ App for Prescribers; Includes Latest Hepatitis C Medication Guidelines for Vosevi
Date:7/26/2017

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, has released an updated version of the HCV Treatment Path app (version 4.4.0) to keep health care providers informed with the latest guidelines for treating chronic hepatitis C virus (HCV) infection. All of the latest HCV medications are included in this app, including Vosevi™ (sofosbuvir/velpatasvir) from Gilead Sciences that was approved by the FDA on July 18, 2017.

This updated edition of the HCV Treatment Path app offers prescribers guidelines and tools to streamline the selection of the hepatitis C treatment that is best-suited to individual patients, based on criteria from experts such as the FDA and the AASLD (American Association for the Study of Liver Diseases). This newly released version app addresses major changes to AASLD guidelines for both treatment naïve and treatment-experienced patients. In addition, the latest treatment options are included, such as the FDA’s recent approval of Vosevi which is a once-daily pill used as salvage therapy in failed initial treatment of HCV genotypes 1-6.

“We’re pleased to get this latest revamped version of the app into the hands of prescribers to guide their decision process for hepatitis C therapy. The treatment landscape for this disease is under continual change and this app keeps the latest information easily accessible,” says Elvin Montanez, Pharm.D., Chief Operations Officer at BioPlus Specialty Pharmacy. “With so many medications available to providers, each with different guidelines and criteria, it is helpful to have one app to review all the latest information when designing an appropriate treatment plan for each patient.”

Learn more about the HCV Treatment Path App here.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 28 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for hepatitis C, cancer, multiple sclerosis, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

###?

Read the full story at http://www.prweb.com/releases/2017/07/prweb14539907.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. BioPlus Specialty Pharmacy Releases New HIPAA-Compliant Mobile App for Physicians: RxCommunicator
2. BioPlus Specialty Pharmacy’s ‘Pay It Forward’ Program Donates $250,000 to Patient Programs
3. BioPlus Specialty Pharmacy Introducing New Technology While Attending the 2016 Asembia Specialty Pharmacy Summit
4. Taltz® Now Available From BioPlus Specialty Pharmacy for Plaque Psoriasis Treatment
5. BioPlus Specialty Pharmacy Releases Version 3.0 of ‘HCV Treatment Path’ App For Prescribers
6. New Patient-Centered Website, BioPlusHealth.com, Launched By BioPlus Specialty Pharmacy
7. BioPlus Specialty Pharmacy Continues Successful ‘Pay It Forward’ Program in 2016
8. BioPlus Specialty Pharmacy to Provide New FDA Approved Hepatitis C Combination Zepatier™ (grazoprevir/elbasvir)
9. BioPlus Specialty Pharmacy Announces Cosentyx® Now Available For Expanded Treatment Indications: Ankylosing Spondylitis and Psoriatic Arthritis
10. ‘Therapy Comfort Care Kits’ Now Delivered To All Cancer Patients at BioPlus Specialty Pharmacy
11. BioPlus Specialty Pharmacy Announces New Vice President of Managed Care: Luis Torres
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: